iStock_000012287833_Large_reverse.jpg
iStock_000048234480_Large copy_2.jpg
iStock_000050498068_Large copy_grey.jpg
iStock_000050495890_Large copy_grey.jpg
iStock_000037527842_Large copy.jpg
iStock_000050498068_Large copy_grey.jpg
iStock_000012287833_Large_reverse.jpg

DISCOVERING TRANSFORMATIVE MEDICINES IN THE IMMUNO-MICROBIOME


Evelo Biosciences is the leading immuno-microbiome company developing immunotherapies for cancer, autoimmune and inflammatory diseases. 

SCROLL DOWN

DISCOVERING TRANSFORMATIVE MEDICINES IN THE IMMUNO-MICROBIOME


Evelo Biosciences is the leading immuno-microbiome company developing immunotherapies for cancer, autoimmune and inflammatory diseases. 

The Immuno-microbiome


The immuno-microbiome is the meta-system comprising the immune system and the microbiome that governs and modulates immune response. Evelo is the first company to focus on characterizing and understanding the biology of the immuno-microbiome to develop next generation immunotherapies across multiple diseases.

 

 

 

SCROLL DOWN

The Immuno-microbiome


The immuno-microbiome is the meta-system comprising the immune system and the microbiome that governs and modulates immune response. Evelo is the first company to focus on characterizing and understanding the biology of the immuno-microbiome to develop next generation immunotherapies across multiple diseases.

 

 

 

iStock_000048234480_Large copy_2.jpg

Platform


We have a broad discovery, development and manufacturing platform that combines expertise in microbiology, immunology, pharmacology and computational biology.  We are focused on the pharmacological interactions between the immune system and the microbiome and have identified specific bacteria that have the ability to modulate the immune system in defined ways.

 

SCROLL DOWN

Platform


We have a broad discovery, development and manufacturing platform that combines expertise in microbiology, immunology, pharmacology and computational biology.  We are focused on the pharmacological interactions between the immune system and the microbiome and have identified specific bacteria that have the ability to modulate the immune system in defined ways.

 

Products


We are developing bacterial-based therapeutics to treat cancer, autoimmune and inflammatory diseases.  These therapeutics leverage the ability of specific strains of bacteria to potently activate the immune system against tumors and down-regulate the immune system for the treatment of autoimmune and inflammatory diseases.  We have identified several drug candidates for oral delivery, with the potential for many more.

SCROLL DOWN

Products


We are developing bacterial-based therapeutics to treat cancer, autoimmune and inflammatory diseases.  These therapeutics leverage the ability of specific strains of bacteria to potently activate the immune system against tumors and down-regulate the immune system for the treatment of autoimmune and inflammatory diseases.  We have identified several drug candidates for oral delivery, with the potential for many more.

 

iStock_000050498068_Large copy_grey.jpg

Board of Directors


Evelo's Board of Directors combines expertise across industry, academia, drug development and the investment community, unified by the mission to improve the lives of patients.

SCROLL DOWN

Board of Directors


Evelo's Board of Directors combines expertise across industry, academia, drug development and the investment community, unified by the mission to improve the lives of patients.

SIMBA GILL

CEO - Evelo Biosciences

 

NOUBAR AFEYAN

Founder, Sr. Managing Partner, CEO - Flagship Ventures

 

DAVID BERRY

General Partner - Flagship Ventures

 

Mark Pruzanski

Founder, CEO, President - Intercept Pharmaceuticals

 

DAVID pERRY

CEO - Indigo Agriculture

iStock_000050495890_Large copy_grey.jpg

Leadership


SIMBA GILL

CEO - Evelo Biosciences

 

Mark Bodmer

Chief Scientific Officer & President of R&D

 

Kareem Reda

Vice President Business Development  & Strategy

 

William DeVaul

Vice President Intellectual Property

 

Jackie Papkoff

Senior Vice President, Research

 

Derek Adams

Senior Vice President, CMC

 

Anil Jina

Chief Medical Officer

SCROLL DOWN

Leadership


SIMBA GILL

CEO - Evelo Biosciences

 

Mark Bodmer

Chief Scientific Officer & President of R&D

 

Kareem Reda

Vice President Business Development  & Strategy

 

William DeVaul

Vice President Intellectual Property

 

Jackie Papkoff

Senior Vice President, Research

 

Derek Adams

Senior Vice President, CMC

 

Anil Jina

Chief Medical Officer

Founders & Investors


SCROLL DOWN

Founders & Investors


 
 
iStock_000037527842_Large copy.jpg

News


EVELO BIOSCIENCES AND Mayo Clinic Establish Research Collaboration for Immuno-microbiome cancer therapies 

Cambridge, Mass. - August 2, 2016

MORE

 

EVELO BIOSCIENCES and epiva Biosciences merge to create the leading immuno-microbiome company

Cambridge, Mass. - July 12, 2016

MORE

 

EVELO BIOSCIENCES PARTICIPATES IN WHITE HOUSE OFFICE OF SCIENCE AND TECHNOLOGY POLICY'S NATIONAL MICROBIOME INITIATIVE EVENT

Cambridge, Mass. - May 13, 2016

MORE

 

EVELO BIOSCIENCES ANNOUNCES PARTICIPATION AT GUGGENHEIM MICROBIOME DAY

Cambridge, Mass. - April 14, 2016

MORE

 

Uchicago and evelo biosciences sign licensing deal for microbiome-based cancer immunotherapy

Cambridge, Mass. - April 7, 2016

MORE

 

 

PRESS RELEASE ARCHIVE

SCROLL DOWN

News


EVELO BIOSCIENCES AND Mayo Clinic Establish Research Collaboration for Immuno-microbiome cancer therapies 

Cambridge, Mass. - August 2, 2016

MORE

 

EVELO BIOSCIENCES and epiva Biosciences merge to create the leading immuno-microbiome company

Cambridge, Mass. - July 12, 2016

MORE

 

EVELO BIOSCIENCES PARTICIPATES IN WHITE HOUSE OFFICE OF SCIENCE AND TECHNOLOGY POLICY'S NATIONAL MICROBIOME INITIATIVE EVENT

Cambridge, Mass. - May 13, 2016

MORE

 

EVELO BIOSCIENCES ANNOUNCES PARTICIPATION AT GUGGENHEIM MICROBIOME DAY

Cambridge, Mass. - April 14, 2016

MORE

 

Uchicago and evelo biosciences sign licensing deal for microbiome-based cancer immunotherapy

Cambridge, Mass. - April 7, 2016

MORE

 

 

PRESS RELEASE ARCHIVE

iStock_000050498068_Large copy_grey.jpg

If you want to make a difference, we should talk


 

To join an exceptional team of innovators, please visit our opportunities page.

 

SCROLL DOWN

If you want to make a difference, we should talk


 

To join an exceptional team of innovators, please visit our opportunities page.

 

Contact


620 Memorial Drive | Suite 200 West | Cambridge, MA, 02139 USA

info@evelobio.com

+ 1 (617) 577-0300

SCROLL DOWN

Contact


620 Memorial Drive | Suite 200 West | Cambridge, MA, 02139 USA

info@evelobio.com

+ 1 (617) 577-0300